Literature DB >> 412475

Action of Nitroglycerin and amyl nitrite in labile and essential hypertension: hemodynamic differences.

S G Chrysant, F G Dunn, J G De Carvalho, P N Adamopoulos, E D Frolich.   

Abstract

Seventeen patients with labile hypertension received nitroglycerin and 18 received amyl nitrite. Twelve patients with established essential hypertension received nitroglycerin and 12 received amyl nitrite. Nitroglycerin reduced the systolic and mean arterial pressures and cardiac output in both groups, but had no effect on diastolic pressure and total peripheral resistance. Amyl nitrite decreased systolic, diastolic, and mean arterial pressures and peripheral vascular resistance and increased heart rate and cardiac output in labile hypertensives. In established hypertensive patients, amyl nitrite decreased systolic, diastolic, and mean arterial pressures and cardiac output, and had little effect on peripheral vascular resistance. Nitroglycerin reduced arterial pressure in labile and established hypertensives through venodilation and peripheral venous pooling. Amyl nitrite and effects similar to nitroglycerin in established hypertensives; in labile hypertensives it reduced arterial pressure through arterial dilation and a decrease in peripheral vascular resistance.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412475

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  8 in total

Review 1.  Nitrates and nitrites in the treatment of ischemic cardiac disease.

Authors:  Vaughn E Nossaman; Bobby D Nossaman; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Jul-Aug       Impact factor: 2.644

2.  Hypertension research program at ochsner: a program in translational research.

Authors:  Edward Frohlich
Journal:  Ochsner J       Date:  2002

3.  Blockade of slow calcium channels and regulation of circulatory pressor responses in uncomplicated hypertension.

Authors:  B Silke; R C Ahuja; R C Okoli; G I Nelson; S H Taylor
Journal:  Ir J Med Sci       Date:  1983-10       Impact factor: 1.568

Review 4.  Calcium antagonists. Clinical use in the treatment of systemic hypertension.

Authors:  C Spivack; S Ocken; W H Frishman
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

5.  Acute and chronic effects of nifedipine in arterial hypertension.

Authors:  O L Pedersen; E Mikkelsen
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

6.  Cardiovascular, baroreflex and humoral responses in hypertensive patients during nicardipine therapy.

Authors:  P Coruzzi; A Biggi; L Musiari; C Ravanetti; A Novarini
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Effect of nitroglycerin on peripheral large arteries in hypertension.

Authors:  A C Simon; J A Levenson; B Y Levy; J E Bouthier; P P Peronneau; M E Safar
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

8.  Double-blind controlled trial of molsidomine in hypertension.

Authors:  J Milei; A Vazquez; J Lemus
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.